YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Why Are Freshworks (FRSH) Shares Soaring Today What Happened? Shares of business software provider Freshworks (NASDAQ:FRSH) jumped 5.4% in the pre-market session after S&P Dow Jones Indices announced that the company will be added to the S…
Repligen Corporation WALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN, "Repligen", or the "Company"), a life sciences company focused on bioprocessing technology leadership, today announced it has comple…
NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Freshworks Inc. (NASD: FRSH) will replace BioLife Solutions Inc. (NASD:BLFS) in the S&P SmallCap 600 effective prior to the open of trading on Thursday, October 8. S&P MidCap 400 constituent Repligen…
Investing.com -- Freshworks Inc (NASDAQ:FRSH) shares rose 4% in after-hours trading Monday following the announcement that the company will join the S&P SmallCap 600 index. Before you buy NVIDIA: our AI model's stock picks are beating the…
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its "Small Cap Strategy". The letter can be downloaded here. The strategy returned 24.01% in the second quarter, outperforming the Ru…
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to break-even earnings per share a year ago. These figures are adjusted fo…
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Repligen (NasdaqGS:RGEN) and BioLife Solutions recently held a merger and acquisition call. The discussion focused on potential com…
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…
[Business mergers and acquisitions concept. Share acquisition, asset business acquisition, amalgamation. Business review and development model. The abbreviation M and A on smart background, copy space.] Parradee Kietsirikul Here's a list o…
Wall Street's major averages aimed to go higher on Friday but closed mixed as oil prices declined. The benchmark S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_a…
Repligen Corporation RGEN announced that it has entered into a definitive agreement to acquire Washington-based BioLife Solutions BLFS, a leading developer of bioproduction products and services, for a total value of approximately $1.5 bil…
(RTTNews) - The following biotech stocks reached a 52-week high on July 22, 2026, driven by key catalysts including prospective clinical trial results and announced acquisitions. Advanced Biomed Inc. (ADVB) Advanced Biomed is a biotechnolo…
Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index down 0.4% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
July 22 (Reuters) - Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at about $1.5 billion, to expand the drugmaking equipment provider's presence in the fast-growing cell therapy market. The…
(RTTNews) - Repligen Corp. (RGEN), a life sciences company, on Wednesday agreed to acquire BioLife Solutions Inc. (BLFS) in cash-and-stock deal at approximately $1.5 billion, expanding its presence in the fast-growing cell therapy market.…
Repligen Corporation Fast-tracks Repligen's leadership and customer solution offering in high-growth cell therapy market by adding BioLife's differentiated, high-margin recurring revenue business BioLife stockholders to receive cash and Re…
* BioLife Solutions (BLFS [https://seekingalpha.com/symbol/BLFS]), a life sciences company based in Bothell, Washington, has attracted buyout interest from multiple entities, including bioprocessing technology firm Repligen (RGEN [https://…
Prosper Stars & Stripes, a long/short equity fund, recently released its first-quarter 2026 investor letter. A copy of the letter is available to download here. In Q1 2026, the portfolio underperformed with a net return of (-5.6%) compared…
The United States market remained flat over the last week but has seen a 26% increase over the past year, with earnings forecast to grow by 17% annually. In such a market environment, identifying stocks that are trading below their fair va…
Activists also report to the SEC on BioLife Solutions, Garrett Motion, Life Time Group Holdings, Infleqtion, and CBL Properties. Continue Reading
BioLife Solutions logo Key Points Interested in BioLife Solutions, Inc.? Here are five stocks we like better. Q1 2026 results: Revenue was $27.5 million, up 25% year‑over‑year, with adjusted EBITDA of $6.2 million (22% of revenue); managem…
The United States market has seen a robust performance, climbing 3.2% in the last week and rising 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying stocks that are trading be…
The United States market has shown robust growth, with a 3.2% increase over the past week and a remarkable 31% rise over the last year, while earnings are anticipated to grow by 16% annually. In this environment, identifying stocks that ar…
The United States market has shown robust growth, with a 1.8% increase over the last week and a remarkable 30% rise in the past year, while earnings are projected to grow by 16% annually. In such an environment, identifying stocks that are…
The United States market has shown robust performance, climbing 1.8% in the last week and achieving a 30% increase over the past year, with earnings expected to grow by 16% annually. In this thriving environment, identifying stocks that ar…
ResMed (RMD) came out with quarterly earnings of $2.86 per share, beating the Zacks Consensus Estimate of $2.79 per share. This compares to earnings of $2.37 per share a year ago. These figures are adjusted for non-recurring items. This qu…
Over the last 7 days, the United States market has risen by 1.7%, contributing to a remarkable 34% increase over the past year, with earnings anticipated to grow by 16% annually in the coming years. In such a thriving environment, identify…
Utah Medical Products, Inc. UTMD shares have gained 31.5% in the past year against the industry’s 14.8% decline. The company has outperformed other industry players, including GE HealthCare Technologies Inc. GEHC and BioLife Solutions, Inc…
The United States market has recently experienced a robust climb, with a 4.4% increase in the last week and an impressive 32% rise over the past year, while earnings are projected to grow by 16% annually. In this context of strong market p…
Over the last week, the United States market has seen a 4.4% increase, contributing to an impressive 32% rise over the past year, with earnings expected to grow by 16% annually. In such a thriving environment, identifying stocks that are p…
Over the last 7 days, the United States market has risen by 4.2%, contributing to a 29% increase over the past year, with earnings forecasted to grow by 16% annually. In this environment of growth, identifying stocks that may be trading be…
The United States market has shown robust growth, rising 4.2% over the last week and 29% over the past year, with earnings projected to increase by 16% annually. In such a thriving environment, identifying stocks that may be undervalued re…
[Close Up Image Of A Stock Market Graph] solarseven/iStock via Getty Images Benchmark Equity Research on Tuesday released its quarterly update to the firm’s “best ideas” list, featuring 29 high-conviction, catalyst-driven stock picks selec…
Earnings Call Insights: BioLife Solutions (BLFS) Q4 2025 MANAGEMENT VIEW * CEO Roderick de Greef stated that "2025 was another strong year for BioLife, delivering double-digit revenue growth, operating margin expansion and improved profita…
BioLife Solutions logo Key Points Strong 2025 results: Revenue rose 29% to about $96 million, adjusted EBITDA increased to $25 million (26% of revenue), and cash plus marketable securities climbed to $120.2 million following the SAVSU dive…